
Highlights
The global Self-Monitoring Blood Glucose System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Self-Monitoring Blood Glucose System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Self-Monitoring Blood Glucose System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Self-Monitoring Blood Glucose System include Roche, LifeScan, Abbott, Ascensia, ARKRAY, I-SENS, Omron, B. Braun and 77 Elektronika, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Self-Monitoring Blood Glucose System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-Monitoring Blood Glucose System.
The Self-Monitoring Blood Glucose System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Self-Monitoring Blood Glucose System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-Monitoring Blood Glucose System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon
Segment by Type
Blood Glucose Test Strips
Blood Glucose Meter
Segment by Application
Hospital
Household
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Self-Monitoring Blood Glucose System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Self-Monitoring Blood Glucose System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Self-Monitoring Blood Glucose System Market Overview
1.1 Product Overview and Scope of Self-Monitoring Blood Glucose System
1.2 Self-Monitoring Blood Glucose System Segment by Type
1.2.1 Global Self-Monitoring Blood Glucose System Market Value Comparison by Type (2023-2029)
1.2.2 Blood Glucose Test Strips
1.2.3 Blood Glucose Meter
1.3 Self-Monitoring Blood Glucose System Segment by Application
1.3.1 Global Self-Monitoring Blood Glucose System Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Household
1.4 Global Self-Monitoring Blood Glucose System Market Size Estimates and Forecasts
1.4.1 Global Self-Monitoring Blood Glucose System Revenue 2018-2029
1.4.2 Global Self-Monitoring Blood Glucose System Sales 2018-2029
1.4.3 Global Self-Monitoring Blood Glucose System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Self-Monitoring Blood Glucose System Market Competition by Manufacturers
2.1 Global Self-Monitoring Blood Glucose System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Self-Monitoring Blood Glucose System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Self-Monitoring Blood Glucose System Average Price by Manufacturers (2018-2023)
2.4 Global Self-Monitoring Blood Glucose System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Self-Monitoring Blood Glucose System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Self-Monitoring Blood Glucose System, Product Type & Application
2.7 Self-Monitoring Blood Glucose System Market Competitive Situation and Trends
2.7.1 Self-Monitoring Blood Glucose System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Self-Monitoring Blood Glucose System Players Market Share by Revenue
2.7.3 Global Self-Monitoring Blood Glucose System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Self-Monitoring Blood Glucose System Retrospective Market Scenario by Region
3.1 Global Self-Monitoring Blood Glucose System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Self-Monitoring Blood Glucose System Global Self-Monitoring Blood Glucose System Sales by Region: 2018-2029
3.2.1 Global Self-Monitoring Blood Glucose System Sales by Region: 2018-2023
3.2.2 Global Self-Monitoring Blood Glucose System Sales by Region: 2024-2029
3.3 Global Self-Monitoring Blood Glucose System Global Self-Monitoring Blood Glucose System Revenue by Region: 2018-2029
3.3.1 Global Self-Monitoring Blood Glucose System Revenue by Region: 2018-2023
3.3.2 Global Self-Monitoring Blood Glucose System Revenue by Region: 2024-2029
3.4 North America Self-Monitoring Blood Glucose System Market Facts & Figures by Country
3.4.1 North America Self-Monitoring Blood Glucose System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Self-Monitoring Blood Glucose System Sales by Country (2018-2029)
3.4.3 North America Self-Monitoring Blood Glucose System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Self-Monitoring Blood Glucose System Market Facts & Figures by Country
3.5.1 Europe Self-Monitoring Blood Glucose System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Self-Monitoring Blood Glucose System Sales by Country (2018-2029)
3.5.3 Europe Self-Monitoring Blood Glucose System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Self-Monitoring Blood Glucose System Market Facts & Figures by Country
3.6.1 Asia Pacific Self-Monitoring Blood Glucose System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Self-Monitoring Blood Glucose System Sales by Country (2018-2029)
3.6.3 Asia Pacific Self-Monitoring Blood Glucose System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Self-Monitoring Blood Glucose System Market Facts & Figures by Country
3.7.1 Latin America Self-Monitoring Blood Glucose System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Self-Monitoring Blood Glucose System Sales by Country (2018-2029)
3.7.3 Latin America Self-Monitoring Blood Glucose System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Self-Monitoring Blood Glucose System Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-Monitoring Blood Glucose System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Self-Monitoring Blood Glucose System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Self-Monitoring Blood Glucose System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-Monitoring Blood Glucose System Sales by Type (2018-2029)
4.1.1 Global Self-Monitoring Blood Glucose System Sales by Type (2018-2023)
4.1.2 Global Self-Monitoring Blood Glucose System Sales by Type (2024-2029)
4.1.3 Global Self-Monitoring Blood Glucose System Sales Market Share by Type (2018-2029)
4.2 Global Self-Monitoring Blood Glucose System Revenue by Type (2018-2029)
4.2.1 Global Self-Monitoring Blood Glucose System Revenue by Type (2018-2023)
4.2.2 Global Self-Monitoring Blood Glucose System Revenue by Type (2024-2029)
4.2.3 Global Self-Monitoring Blood Glucose System Revenue Market Share by Type (2018-2029)
4.3 Global Self-Monitoring Blood Glucose System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Self-Monitoring Blood Glucose System Sales by Application (2018-2029)
5.1.1 Global Self-Monitoring Blood Glucose System Sales by Application (2018-2023)
5.1.2 Global Self-Monitoring Blood Glucose System Sales by Application (2024-2029)
5.1.3 Global Self-Monitoring Blood Glucose System Sales Market Share by Application (2018-2029)
5.2 Global Self-Monitoring Blood Glucose System Revenue by Application (2018-2029)
5.2.1 Global Self-Monitoring Blood Glucose System Revenue by Application (2018-2023)
5.2.2 Global Self-Monitoring Blood Glucose System Revenue by Application (2024-2029)
5.2.3 Global Self-Monitoring Blood Glucose System Revenue Market Share by Application (2018-2029)
5.3 Global Self-Monitoring Blood Glucose System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Self-Monitoring Blood Glucose System Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 LifeScan
6.2.1 LifeScan Corporation Information
6.2.2 LifeScan Description and Business Overview
6.2.3 LifeScan Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 LifeScan Self-Monitoring Blood Glucose System Product Portfolio
6.2.5 LifeScan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Self-Monitoring Blood Glucose System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ascensia Self-Monitoring Blood Glucose System Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 ARKRAY
6.5.1 ARKRAY Corporation Information
6.5.2 ARKRAY Description and Business Overview
6.5.3 ARKRAY Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ARKRAY Self-Monitoring Blood Glucose System Product Portfolio
6.5.5 ARKRAY Recent Developments/Updates
6.6 I-SENS
6.6.1 I-SENS Corporation Information
6.6.2 I-SENS Description and Business Overview
6.6.3 I-SENS Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 I-SENS Self-Monitoring Blood Glucose System Product Portfolio
6.6.5 I-SENS Recent Developments/Updates
6.7 Omron
6.6.1 Omron Corporation Information
6.6.2 Omron Description and Business Overview
6.6.3 Omron Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Omron Self-Monitoring Blood Glucose System Product Portfolio
6.7.5 Omron Recent Developments/Updates
6.8 B. Braun
6.8.1 B. Braun Corporation Information
6.8.2 B. Braun Description and Business Overview
6.8.3 B. Braun Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 B. Braun Self-Monitoring Blood Glucose System Product Portfolio
6.8.5 B. Braun Recent Developments/Updates
6.9 77 Elektronika
6.9.1 77 Elektronika Corporation Information
6.9.2 77 Elektronika Description and Business Overview
6.9.3 77 Elektronika Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 77 Elektronika Self-Monitoring Blood Glucose System Product Portfolio
6.9.5 77 Elektronika Recent Developments/Updates
6.10 AgaMatrix
6.10.1 AgaMatrix Corporation Information
6.10.2 AgaMatrix Description and Business Overview
6.10.3 AgaMatrix Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AgaMatrix Self-Monitoring Blood Glucose System Product Portfolio
6.10.5 AgaMatrix Recent Developments/Updates
6.11 ALL Medicus
6.11.1 ALL Medicus Corporation Information
6.11.2 ALL Medicus Self-Monitoring Blood Glucose System Description and Business Overview
6.11.3 ALL Medicus Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ALL Medicus Self-Monitoring Blood Glucose System Product Portfolio
6.11.5 ALL Medicus Recent Developments/Updates
6.12 Terumo
6.12.1 Terumo Corporation Information
6.12.2 Terumo Self-Monitoring Blood Glucose System Description and Business Overview
6.12.3 Terumo Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Terumo Self-Monitoring Blood Glucose System Product Portfolio
6.12.5 Terumo Recent Developments/Updates
6.13 Sinocare
6.13.1 Sinocare Corporation Information
6.13.2 Sinocare Self-Monitoring Blood Glucose System Description and Business Overview
6.13.3 Sinocare Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sinocare Self-Monitoring Blood Glucose System Product Portfolio
6.13.5 Sinocare Recent Developments/Updates
6.14 Yicheng
6.14.1 Yicheng Corporation Information
6.14.2 Yicheng Self-Monitoring Blood Glucose System Description and Business Overview
6.14.3 Yicheng Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yicheng Self-Monitoring Blood Glucose System Product Portfolio
6.14.5 Yicheng Recent Developments/Updates
6.15 Yuwell
6.15.1 Yuwell Corporation Information
6.15.2 Yuwell Self-Monitoring Blood Glucose System Description and Business Overview
6.15.3 Yuwell Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yuwell Self-Monitoring Blood Glucose System Product Portfolio
6.15.5 Yuwell Recent Developments/Updates
6.16 Acon
6.16.1 Acon Corporation Information
6.16.2 Acon Self-Monitoring Blood Glucose System Description and Business Overview
6.16.3 Acon Self-Monitoring Blood Glucose System Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Acon Self-Monitoring Blood Glucose System Product Portfolio
6.16.5 Acon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-Monitoring Blood Glucose System Industry Chain Analysis
7.2 Self-Monitoring Blood Glucose System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-Monitoring Blood Glucose System Production Mode & Process
7.4 Self-Monitoring Blood Glucose System Sales and Marketing
7.4.1 Self-Monitoring Blood Glucose System Sales Channels
7.4.2 Self-Monitoring Blood Glucose System Distributors
7.5 Self-Monitoring Blood Glucose System Customers
8 Self-Monitoring Blood Glucose System Market Dynamics
8.1 Self-Monitoring Blood Glucose System Industry Trends
8.2 Self-Monitoring Blood Glucose System Market Drivers
8.3 Self-Monitoring Blood Glucose System Market Challenges
8.4 Self-Monitoring Blood Glucose System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon
Ìý
Ìý
*If Applicable.
